Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a …
MAPJ Asín, M Fernández-Ruiz, F López-Medrano… - Medicine, 2014 - journals.lww.com
Abstract Bacillus Calmette-Guérin (BCG) is the most effective intravesical immunotherapy for
superficial bladder cancer. Although generally well tolerated, BCG-related infectious …
superficial bladder cancer. Although generally well tolerated, BCG-related infectious …
[HTML][HTML] Parapharyngeal tuberculoid mass: A rare complication of Bacillus Calmette‐Guérin therapy for urothelial carcinoma in situ
KA Plonowska‐Hirschfeld, M Fung… - Clinical case …, 2021 - ncbi.nlm.nih.gov
We present the first reported case of a parapharyngeal space mass as manifestation of
disseminated mycobacterial infection following Bacillus Calmette-Guérin (BCG) intravesical …
disseminated mycobacterial infection following Bacillus Calmette-Guérin (BCG) intravesical …
[HTML][HTML] BCG infections
TH Kim - 2020 - series.publisso.de
Bladder cancer is commonly presented as a highly recurring superficial form. Following
endoscopic resection, current practice recommends repeated intravesical instillation of the …
endoscopic resection, current practice recommends repeated intravesical instillation of the …
Mycobacterium bovis BCG infection following intravesicular administration: case report
JA Leis - Reactions, 2011 - Springer
The man presented with a tender suprapubic mass of 3 weeks' duration. Ten months earlier,
he received six intravesical instillations of BCG for bladder carcinoma with no complications …
he received six intravesical instillations of BCG for bladder carcinoma with no complications …